The #1 Retirement Play for 2025
Expert Reveals: The #1 Retirement Play for 2025. "We're Entering the Greatest Energy Bull Market Since the Industrial Revolution" - Larry Benedict
Shares Stats
| Shares Outstanding | 9,860,000 |
| Shares Float | 9,800,000 |
| Shares Short | 120,000 |
| Insider Holdings | 19% |
| Institution Holdings | 2.27% |
About Soligenix Inc
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States. It operates through two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a photodynamic therapy, which has completed Phase 3 clinical trial for the treatment of cutaneous T-cell lymphoma; SGX942, an innate defense regulator (IDR) technology that is in Phase 3 clinical trial for the treatment of inflammatory diseases, including oral mucositis in head and neck cancer; SGX945, an IDR technology that is in Phase 2a study to treat aphthous ulcers in Behçet's disease; and SGX302, an IDR technology, which is in Phase 2a study for the treatment of mild-to-moderate psoriasis. Its Public Health Solutions segment engages in the development of RiVax, a ricin toxin vaccine candidate, which has completed Phase 1a, 1b, and 1c clinical trials; SGX943, a therapeutic candidate in preclinical studies for the treatment of antibiotic-resistant and emerging infectious diseases; ThermoVax, a technology in pre-clinical development for thermostabilizing vaccines; CiVax, a vaccine candidate for the prevention of COVID-19; and vaccine programs that target filoviruses, such as Marburg and Ebola. The company was formerly known as DOR BioPharma, Inc. and changed its name to Soligenix, Inc. in September 2009. Soligenix, Inc. was incorporated in 1987 and is headquartered in Princeton, New Jersey.
General
| Name | Soligenix Inc |
| Ticker | SNGX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 14 |
Highlights
| Analyst Target | 10.00 |
| Market Cap | 16,500,000 |
| PEG Ratio | -1.52 |
| EBITDA | -11,364,169 |
Financials
| Curr Year EPS Estimate | -2.60 |
| Next Quarter EPS Estimate | -0.48 |
| Return on Assets | -0.91 |
| Return on Equity | -3.91 |
| Earnings Per Share | -2.90 |
| Quarterly Revenue Growth | -1 |
Valuation
| Price/Sales (Trailing 12 Mt.) | 3,874.85 |
| Price/Book (Most Recent Quarter) | 5.86 |
Earnings
Stock Market Today: Nasdaq, Dow Jones Futures Rise, Bank Of America, Morgan Stanley, Abbott In Focus—Analyst Warns US 'Going Broke Slowly'
U.S. stock futures advanced on Wednesday following Tuesday’s mixed close. Futures of major benchmark indices were higher.
How Promote Giving, a new investment model, will raise millions for charities
The first foreign trip Joel Holsinger took in 2019 after joining the board of directors at the global health nonprofit PATH convinced him that he needed to do more to raise money for charities.
Elon's New Device Could Launch Biggest IPO of the Decade - Ad
Elon Musk's new device is being called a "game-changer"-and even the White House is using this tech. Jeff Brown says it could launch Musk's next trillion-dollar company and make early investors rich. You can claim a stake now for as little as $500.
Indonesia finds traces of radioactive element at clove farm
JAKARTA, Indonesia (AP) — Indonesia detected traces of radioactive cesium 137 at a clove plantation as it searches for the source of radioactive contamination that forced recalls of shrimp and spices exported to the U.S., a task force investigating the issue said Wednesday.
Ryder Cup 2025 Tees Off With $200 Million Economic Boost: Stocks To Watch
The 2025 Ryder Cup teed off at Bethpage State Park on Long Island Friday, drawing over 250,000 fans and expected to deliver a $200 million economic boost to New York State and surrounding businesses.
Could $1 Stock Be Sitting on a Billion-Dollar Discovery? - Ad
This $1 stock has already made its mark with a listing on the prestigious NYSE. Now, it's sitting on prime land in one of America's richest gold districts, with the potential for a billion-dollar discovery. For savvy investors, this may be a $1 "Golden Ticket" to massive returns.
Steve Jobs Taught Guy Kawasaki Don't Make Things 'Slightly Better' — Here Is What The Apple Co-Founder Thought About Big Changes And Big Money
Guy Kawasaki learned from Steve Jobs that the biggest impact comes from bold leaps, not small tweaks. Being mission-driven is key to success.
Cathie Wood, Tom Lee Align On These 10 Stock Picks: Some Might Surprise You
A new ETF from Tom Lee shares 10 stocks in common with Cathie Wood's Ark Funds. A look at the stocks both well-known financial figures like.
October 16: D-Day For The Dollar - Ad
A quiet shift in U.S. law has just authorized private companies to mint a new form of government-authorized money called the "Dollar 2.0"... and the next major mint hits on October 16. Investors who make the right moves before then could make up to 40X by 2032...
Retail Investors Gain Access To Private Credit Market Via This New ETF
Simplify Asset Management and VettaFi have introduced a new exchange-traded fund (ETF) that enables retail investors to tap into the rapidly growing private credit market.
Why Bunge Stock Is Gaining Wednesday
Bunge shares rose after post-Viterra reorganization and clearer four-segment reporting, plus a recast FY25 EPS outlook.
Why Is Wall Street Moving Their Money Overnight? - Ad
Something far more consequential for your money than tariffs is unfolding behind the scenes... Tucked inside this overlooked directive is a plan set to be executed for the first time in in U.S. history. One Stansberry Research's Senior Partner says it's set to trigger a rare window for potentially explosive gains in ONE asset immediately. (Not AI or crypto). Wall Street insiders are already positioning themselves... and he insists you should, too, before it's too late.
USA Rare Earth (USAR) Stock Is Rising Today: Here's Why
Shares of USA Rare Earth, Inc. (NASDAQ: USAR) are trading higher Monday amid a wave of optimism for rare earth materials companies.
Doug Lebda, Founder And CEO Of LendingTree, Dies In ATV Accident
The founder and CEO of LendingTree, tragically passed away this past weekend.
Elon's $25 Trillion Confession - Ad
Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.
Trump's Crypto Czar, Mideast Envoy Under Scrutiny As Elissa Slotkin Seeks Probe Into David Sacks, Steve Witkoff's Alleged UAE Crypto Gains
Sen. Elizabeth Warren (D-Mass.) and Sen. Elissa Slotkin (D-Mich.) demanded an investigation Wednesday into potential conflicts of interest concerning Trump administration officials David Sacks and Steve Witkoff, and their association with the World Liberty Financial cryptocurrency venture.
Patrick Zalupski's group closes on its purchase of the Tampa Bay Rays
NEW YORK (AP) — A group led by Florida-based real estate developer Patrick Zalupski closed on its purchase of the Tampa Bay Rays on Tuesday, finalizing the sale of the team from former owner Stuart Sternberg.
Nvidia CEO Makes First Ever Tesla Announcement - Ad
While Tesla's car sales slump, Nvidia's CEO says Tesla could lead a multi-trillion-dollar AI revolution. He's backing what's being called "Manifested AI" - a 25,000% growth market. And one tiny stock, 168x smaller than Nvidia, could be your way in before the world catches on.
CCDOG Themed On 'Courage The Cowardly Dog' Explodes 86% After Joining 'Forces' With Shiba Inu
A memecoin based on the iconic “Courage the Cowardly Dog” cartoon figure soared Wednesday after being promoted by the Shiba Inu (CRYPTO: SHIB) ecosystem.
MP Materials Tops List For Rare Earth Exposure, Says Analyst
Rare earth stocks are gaining attention as demand for magnets in EVs, robotics, and advanced air mobility is set to double by 2035.
Why Are Wall Street Insiders Moving Their Money to This One Asset? - Ad
Something far more consequential for your money than tariffs is unfolding behind the scenes... Tucked inside this overlooked directive is a plan set to be executed for the first time in in U.S. history. One Stansberry Research's Senior Partner says it's set to trigger a rare window for potentially explosive gains in ONE asset immediately. (Not AI or crypto). Wall Street insiders are already positioning themselves... and he insists you should, too, before it's too late.
Short Squeeze in Silver and Rare Earths, Taco Traders Euphoric, Trump Seeks Diplomatic Path
To gain an edge, this is what you need to know today.
Desperate search for fuel in Mali's capital as al-Qaida-linked group enforces blockade
BAMAKO, Mali (AP) — Endless lines stretched in front of gas stations in Mali’s capital Bamako late into Monday night, as commuters desperately tried to find fuel. Residents are starting to feel the impact of to the city declared in early September by a militant group affiliated with al-Qaida.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
EPAM Joins Oracle To Boost AI And Cloud For Businesses
EPAM deepens partnership with Oracle to help companies in various sectors adopt OCI and AI services, leveraging their expertise.
Ethereum Crashes To $4,100 As Senate Democrats Take Aim At DeFi
Ethereum (CRYPTO: ETH) is trading near $4,100 on Friday, after a sharp selloff that followed its rejection from $4,700 and renewed fears of U.S.
Central Banks Demand More Gold - This $1 Firm Could Supply It - Ad
This tiny company is currently sitting on one of America's largest deposits of gold... land that was hidden away from the public for over 60 years. With Central Banks demanding gold to combat inflation - miners like this one show huge potential for investors
Regeneron's Gene Therapy Shows Significant Gains In Genetic Hearing Loss
Regeneron gene therapy for OTOF-related hearing loss shows rapid, sustained improvements, including normal hearing in some participants.
Mysterious drone flights in NATO airspace have caused alarm across Europe. Here's what we know
BERLIN (AP) — Mysterious drone flights over the airspace of European Union member countries in recent weeks have alarmed the public and elected officials.
The #1 Retirement Play for 2025 - Ad
Expert Reveals: The #1 Retirement Play for 2025. "We're Entering the Greatest Energy Bull Market Since the Industrial Revolution" - Larry Benedict
Trump Ally Laura Loomer Turns on Him Over Qatar Military Base Plan, Calls It a 'Betrayal'
Laura Loomer, a staunch supporter of President Donald Trump, has voiced her dissatisfaction with the president's decision to permit a Qatari air force facility in Idaho.
Nanobiotix-J&J Therapy Shows Promise In Tough Head And Neck Cancer
Nanobiotix reported updated Phase 1 trial data for JNJ-1900 in head and neck cancer, showing strong disease control and survival outcomes.
Elon's New Device Could Launch Biggest IPO of the Decade - Ad
Elon Musk's new device is being called a "game-changer"-and even the White House is using this tech. Jeff Brown says it could launch Musk's next trillion-dollar company and make early investors rich. You can claim a stake now for as little as $500.
Cathie Wood's China Bet: Ark Buys Alibaba's AI Surge And Baidu's Autonomous Future, Dump's Stock Of Crypto-Pivot Brera
On Tuesday, Cathie Wood-led Ark Invest made significant trades involving Baidu Inc. (NASDAQ:BIDU), Alibaba Group Holding Ltd.
Macron is set to appoint a new French prime minister in last-ditch move to tackle turmoil
PARIS (AP) — After a week of intense political turmoil, French President is set to appoint a new prime minister Friday in his latest bid to break the political deadlock that has gripped the country for more than a year, as France struggles with mounting economic challenges and ballooning debt.
Could $1 Stock Be Sitting on a Billion-Dollar Discovery? - Ad
This $1 stock has already made its mark with a listing on the prestigious NYSE. Now, it's sitting on prime land in one of America's richest gold districts, with the potential for a billion-dollar discovery. For savvy investors, this may be a $1 "Golden Ticket" to massive returns.
$1000 Invested In Alnylam Pharmaceuticals 5 Years Ago Would Be Worth This Much Today
Alnylam Pharmaceuticals (NASDAQ: ALNY) has outperformed the market over the past 5 years by 10.45% on an annualized basis producing an average annual return of 25.22%. Currently, Alnylam Pharmaceuticals has a market capitalization of $57.78 billion.
Tesla offers cheaper version of its best-selling EV in bid to win back market share in a tough year
NEW YORK (AP) — Tesla announced the rollout of a new, cheaper version of its best-selling electric car on Tuesday in hopes the offering will help revive flagging sales.
October 16: D-Day For The Dollar - Ad
A quiet shift in U.S. law has just authorized private companies to mint a new form of government-authorized money called the "Dollar 2.0"... and the next major mint hits on October 16. Investors who make the right moves before then could make up to 40X by 2032...
PepsiCo May See Lower Q3 Gross Margins From Tariff Pressure, 'Stretched' Frito-Lay Pricing
PepsiCo, Inc. (NASDAQ: PEP) shares are trading slightly higher on Friday.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.